Paper40969876
Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer.
Kashkush A and 3 others. ACS Pharmacol Transl Sci, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer. Papers, record 40969876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40969876
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38498697 | Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. | J Med Chem | 2024 | https://conductscience.org/library/papers/38498697 | PubMed |
| 2 | 26965148 | Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. | Prog Lipid Res | 2016 | https://conductscience.org/library/papers/26965148 | PubMed |
| 3 | 29721062 | Expression of Minichromosome Maintenance Proteins (MCM) and Cancer Prognosis: A meta-analysis. | J Cancer | 2018 | https://conductscience.org/library/papers/29721062 | PubMed |
| 4 | 22048459 | Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortex. | Neuropsychopharmacology | 2012 | https://conductscience.org/library/papers/22048459 | PubMed |
| 5 | 36130940 | Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/36130940 | PubMed |
| 6 | 30646937 | The role of the endocannabinoid system in female reproductive tissues. | J Ovarian Res | 2019 | https://conductscience.org/library/papers/30646937 | PubMed |
| 7 | 38975893 | DrugMetric: quantitative drug-likeness scoring based on chemical space distance. | Brief Bioinform | 2024 | https://conductscience.org/library/papers/38975893 | PubMed |
| 8 | 34500853 | CB1 Cannabinoid Receptor Signaling and Biased Signaling. | Molecules | 2021 | https://conductscience.org/library/papers/34500853 | PubMed |
| 9 | 40188374 | Advancing target validation with PROTAC technology. | Expert Opin Drug Discov | 2025 | https://conductscience.org/library/papers/40188374 | PubMed |
| 10 | 21074634 | The graphical representation of ADME-related molecule properties for medicinal chemists. | Drug Discov Today | 2011 | https://conductscience.org/library/papers/21074634 | PubMed |
| 11 | 33177502 | Organized cannabinoid receptor distribution in neurons revealed by super-resolution fluorescence imaging. | Nat Commun | 2020 | https://conductscience.org/library/papers/33177502 | PubMed |
| 12 | 18054734 | Cannabinoid-1 receptor antagonists in type-2 diabetes. | Best Pract Res Clin Endocrinol Metab | 2007 | https://conductscience.org/library/papers/18054734 | PubMed |
| 13 | 39245959 | The Endocannabinoid System in Alzheimer's Disease: A Network Meta-Analysis. | J Neurosci Res | 2024 | https://conductscience.org/library/papers/39245959 | PubMed |
| 14 | 38891847 | Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38891847 | PubMed |
| 15 | 12934069 | The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. | Cell Death Differ | 2003 | https://conductscience.org/library/papers/12934069 | PubMed |
| 16 | 37084596 | Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell lines. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37084596 | PubMed |
| 17 | 39914223 | Proteolysis targeting chimera of BI-2536 induces potent dual degradation of PLK1 and BET proteins. | Bioorg Med Chem | 2025 | https://conductscience.org/library/papers/39914223 | PubMed |
| 18 | 39834300 | A patent review of von Hippel-Lindau (VHL)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present). | Expert Opin Ther Pat | 2025 | https://conductscience.org/library/papers/39834300 | PubMed |
| 19 | 20664173 | Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. | J Clin Invest | 2010 | https://conductscience.org/library/papers/20664173 | PubMed |
| 20 | 21773005 | Rimonabant: From RIO to Ban. | J Obes | 2011 | https://conductscience.org/library/papers/21773005 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42934270 | Molecular glue mediated degradation of cannabinoid receptor 1 for cancer therapy. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42934270 |
Source PubMed
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CNR1 | 1268 | PubTator's text mining | https://conductscience.org/library/genes/1268 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40969876
GET https://conductscience.org/api/papers/v1/40969876/references?page=2